Dana Aman
Medical · Yuba City, CANPI 1164060182
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $43.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$979
- Sun Pharmaceutical Industries Inc.$809
- Incyte Corporation$429
- Sanofi$402
- Almirall LLC$340
- plus $2K from 15 others
What the payments were for
- Food & beverage$6,24193%
- Education$4947%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $1,322 |
| Johnson & Johnson | 20 | $979 |
| Sun Pharmaceutical Industries Inc. | 18 | $809 |
| Incyte Corporation | 13 | $429 |
| Sanofi | 9 | $402 |
| Almirall LLC | 9 | $340 |
| Pfizer | 9 | $308 |
| E.r. Squibb & Sons, L.L.C. | 5 | $271 |
| Novartis | 6 | $259 |
| Amgen | 6 | $256 |
| Lilly USA, LLC | 2 | $246 |
| Galderma Laboratories, L.p. | 6 | $227 |
| Dermavant Sciences, Inc. | 3 | $212 |
| Regeneron Healthcare Solutions, Inc. | 6 | $196 |
| UCB, Inc. | 4 | $191 |
| Janssen Scientific Affairs, LLC | 1 | $150 |
| VYNE Pharmaceuticals Inc. | 1 | $40 |
| Boehringer Ingelheim | 1 | $35 |
| Organon | 1 | $23 |
| LEO Pharma Inc. | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,735 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 45 | $2,641 |
| Clobetasol Propionate | 28 | $756 |
| Doxycycline Hyclate | 32 | $504 |
| Triamcinolone Acetonide | 44 | $458 |
| Gentamicin Sulfate | 13 | $447 |
| Minoxidil | 20 | $238 |
| ValacyclovirValacyclovir Hcl | 15 | $229 |
| Ketoconazole | 12 | $212 |
| Hydrocortisone | 15 | $55 |
Paid to pharmacies, not to this prescriber.
Other medical in Yuba City
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.